ABBOTT LABORATORIES Aktie

 

read more...

META, PLTR and ABT lead this week's Zacks blog as AI growth, strong pipelines and solid earnings drive investor interest....

Abbott (ABT) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock....

Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of trading....

NORTH CHICAGO (dpa-AFX) - Abbott Laboratories (ABT) Monday said that its i-STAT TBI test cartridge for use with whole blood has been approved by the Health Canada.The test, run on Abbott's portabl......

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

Abbott (ABT) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects....

Abbott Laboratories has outperformed the Health Care sector over the past year, and analysts are highly optimistic about the stock's prospects....

Coca-Cola, Abbott and AT&T shine in Zacks' latest reports, with each outperforming peers year-to-date despite headwinds in key segments....

NORTH CHICAGO (dpa-AFX) - Abbott Laboratories (ABT) announced Tuesday that the U.S. Food and Drug Administration (FDA) has approved the company's Tendyne transcatheter mitral valve replacement (TM......

NORTH CHICAGO (dpa-AFX) - Abbott Laboratories (ABT) Thursday announced positive data from REFLECT studies of its FreeStyle Libre continuous glucose monitoring (CGM) technology.The REFLECT studies,......

DUBLIN--(BUSINESS WIRE)--The "Implantable Medical Devices Market (2025 Edition): Analysis By Nature Type (Passive Implant, and Active Implant), By Product Type, By Material Type, By Application, By End-User, By Region, By Country: Market Insights and Forecast (2021-2031)" report has been added to ResearchAndMarkets.com's offering. The Global Implantable Medical Devices market showcased growth at a CAGR of 6.04% during 2021-2024. The market was valued at USD 92.89 Billion in 2024 which is expected to reach USD 148.76 Billion in 2031. The global implantable medical devices market is highly competitive, with key players continuously investing in research, product development, and strategic partnerships to maintain their market positions. Leading companies include Medtronic Plc, Johnson & Johnson, and Abbott Laboratories. These companies focus on innovation, mergers and acquisitions, and geographic expansion to strengthen their market presence. The industry is also witnessing a shift towards smart implants, ...

As Abbott Laboratories has outperformed the broader market over the past year, Wall Street analysts maintain a bullish outlook on the stock's prospects....

NVIDIA, Abbott Laboratories, Linde and Tredegar are part of the Zacks top Analyst Blog...

Today's Research Daily features new research reports on 16 major stocks, including NVIDIA Corp. (NVDA), Abbott Laboratories (ABT) and Linde plc (LIN), as well as a micro-cap stock Tredegar Corp. (TG)....

Robert Ford, Abbott Labs CEO, joins 'Power Lunch' to discuss government spending on health care and technological investments....

Blount, Sally E. - Aufsichtsrat - Tag der Transaktion: 2025-04-30...

NORTH CHICAGO (dpa-AFX) - Abbott Laboratories (ABT), the global leader in continuous glucose monitoring (CGM) biowearable technology, announced Tuesday that it has entered a first-of-its-kind agre......

Abbott Laboratories, Boston Scientific and Medtronic are included in this Analyst Blog....

Today's Research Daily features new research reports on 16 major stocks, including The Coca-Cola Co. (KO), Abbott Laboratories (ABT) and RTX Corp. (RTX), as well as two micro-cap stocks Investors Title Co. (ITIC) and Armanino Foods of Distinction, Inc. (AMNF)....